Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents.
Morice CK, Yammine L, Yoon J, Lane SD, Schmitz JM, Kosten TR, De La Garza R 2nd, Verrico CD. Morice CK, et al. Among authors: de la garza r 2nd. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Apr 20;115:110506. doi: 10.1016/j.pnpbp.2021.110506. Epub 2022 Jan 5. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34995723 Review.
Reply to Drs. Hart and Cadet: we agree-the challenges of increasing equity, diversity and inclusion include societal issues and actions now are vital.
Henningfield JE, Fields S, Anthony JC, Brown LS Jr, Bolaños-Guzmán CA, Comer SD, De La Garza R 2nd, Furr-Holden D, Garcia-Romeu A, Hatsukami D, Raznahan A, Zarate CA Jr. Henningfield JE, et al. Among authors: de la garza r 2nd. Neuropsychopharmacology. 2021 Apr;46(5):878-879. doi: 10.1038/s41386-020-00921-3. Epub 2021 Feb 8. Neuropsychopharmacology. 2021. PMID: 33558676 Free PMC article. No abstract available.
Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress.
Henningfield JE, Fields S, Anthony JC, Brown LS Jr, Bolaños-Guzmán CA, Comer SD, De La Garza R 2nd, Furr-Holden D, Garcia-Romeu A, Hatsukami DK, Raznahan A, Zarate CA. Henningfield JE, et al. Among authors: de la garza r 2nd. Neuropsychopharmacology. 2021 Apr;46(5):871-876. doi: 10.1038/s41386-020-0784-y. Epub 2020 Aug 3. Neuropsychopharmacology. 2021. PMID: 32746445 Free PMC article.
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R 2nd, Kosten TR, Verrico CD. Holst M, et al. Among authors: de la garza r 2nd. Am J Addict. 2019 Nov;28(6):455-464. doi: 10.1111/ajad.12959. Epub 2019 Sep 4. Am J Addict. 2019. PMID: 31483544 Clinical Trial.
122 results